|
⚲
|
| Keyboard |
| Neal James R
✚
|
|
|---|---|
| CIK # | 0001600865 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001600865] | |
| 4 | [0001600865] | |
| 5 | [0001600865] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Neal James R | |
| Processa Pharmaceuticals Inc | |
| Morria Biopharmaceuticals PLC | |
| Peak Bio Inc | |
| Palisade Bio Inc | |
| XOMA Royalty Corp | |
| Monterey Innovation Acquisition Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Morria Biopharmaceuticals PLC AKTX
Pre-Funded Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 3,093 | $0.40 | 1,237 |
|
Morria Biopharmaceuticals PLC AKTX
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
|
2025-12-16 | Buy | 2,473 | ||
|
Morria Biopharmaceuticals PLC AKTX
Pre-Funded Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 2,473 | $0.40 | 989 |
|
Morria Biopharmaceuticals PLC AKTX
Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 3,093 | ||
|
Processa Pharmaceuticals Inc PCSA
Restricted Stock Units · derivative
|
2025-10-01 | Grant | 100,000 | $0.00 | |
|
Processa Pharmaceuticals Inc PCSA
Stock Options (Right to Buy) · derivative
|
2025-10-01 | Grant | 300,000 | $0.00 | |
|
Processa Pharmaceuticals Inc PCSA
Restricted Stock · derivative
|
2025-07-24 | Grant | 175,299 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2025-03-20 | Grant | 175,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2025-03-20 | Grant | 225,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Series A Warrants (Right to Buy) · derivative
|
2025-03-06 | Grant | 4,464 | $1.12 | 5,000 |
|
Morria Biopharmaceuticals PLC AKTX
American Depositary Shares representing Ordinary Shares
|
2025-03-06 | Grant | 4,464 | $1.12 | 5,000 |
|
Morria Biopharmaceuticals PLC AKTX
Series B Warrants (Right to Buy) · derivative
|
2025-03-06 | Grant | 4,464 | $1.12 | 5,000 |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2025-01-09 | Grant | 8,000,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-12-23 | Grant | 2,000,000 | $0.00 | |
|
Peak Bio Inc PKBO
Common Stock
|
2024-11-14 | Conversion | 37,850 | ||
|
Peak Bio Inc PKBO
Common Stock
|
2024-11-14 | Disposed to issuer | 37,850 | ||
|
Peak Bio Inc PKBO
Stock Option (Right to Buy) · derivative
|
2024-11-14 | Disposed to issuer | $0.00 | ||
|
Peak Bio Inc PKBO
Convertible Notes · derivative
|
2024-11-14 | Conversion | 33,340 | ||
|
Peak Bio Inc PKBO
Warrant (Right to Purchase) · derivative
|
2024-11-14 | Disposed to issuer | 500,000 | ||
|
Processa Pharmaceuticals Inc PCSA
Restricted Stock · derivative
|
2024-09-03 | Grant | 31,206 | $0.00 | |
| showing 20 of 153 most recent transactions | |||||